SS Innovations International Inc. (NASDAQ: SSII) has announced record second-quarter revenue of $13.9 million, a 39.4% increase year over year, driven by continued demand for its SSi Mantra surgical robotic system. The company also reported first-half revenue of $25.0 million, up 65.6% from the same period in 2025, signaling robust growth in its core business.
The revenue surge is underpinned by a 30.4% rise in SSi Mantra installations during the quarter, reaching 30 systems. This brings the total installed base to 224 systems across 12 countries, with cumulative surgeries exceeding 12,272. The expansion reflects growing adoption of the platform in diverse healthcare markets, positioning SS Innovations as a key player in the global surgical robotics arena.
While system installations remain the primary commercial growth driver, the company is making strides in telesurgery, which extends the clinical profile of SSi Mantra. These advancements could open new avenues for remote surgical procedures, potentially transforming access to specialized care in underserved regions.
Looking ahead, regulatory milestones in major markets could serve as significant catalysts. SS Innovations is targeting FDA clearance by the first quarter of 2027 and EU CE marking by the end of 2026. Achieving these approvals would not only bolster the company's credibility but also unlock access to the lucrative U.S. and European markets, where demand for minimally invasive surgical technologies is high.
The financial results for the second quarter showed gross profit of $7.1 million, a 20.0% increase from the prior year, though gross margin declined to 50.9% from 59.1%, reflecting costs associated with scaling operations and expanding the installed base. For the first half, gross profit rose 77.5% to $12.4 million, with an improved gross margin compared to the prior-year period.
SS Innovations' performance underscores a broader trend in the medical device industry toward robotic-assisted surgery, which offers benefits such as precision, reduced recovery times, and improved patient outcomes. As the company continues to expand its footprint and achieve regulatory milestones, it is poised to capitalize on this growing market.
For more information on SS Innovations, visit the company's newsroom at https://nnw.fm/SSII.
